AKRO(Delisted)
Akero Therapeutics·NASDAQ
--
--(--)
4.76 / 10
Neutral
Fund flow strong (7.26/10) with small/large inflows positive, yet overall/block trends negative. Analysts uniformly neutral (4/4 ratings), historical win rates split (50–100%). Mixed signals require close monitoring.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-10
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for AKRO?
- AKRO holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.76/10 (Neutral).
